Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 18, 2025, Adocia SA (ADOC.PA) has a market cap of $79.206 million USD. According to our data, Adocia SA is ranked No.7760 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 18, 2025 | $79.21 M |
-35.94%
|
| Dec 31, 2024 | $0.12 B |
-47.92%
|
| Dec 29, 2023 | $0.24 B |
190.68%
|
| Dec 30, 2022 | $81.67 M |
-50.99%
|
| Dec 31, 2021 | $0.17 B |
-2.41%
|
| Dec 31, 2020 | $0.17 B |
-16.16%
|
| Dec 31, 2019 | $0.20 B |
-40.15%
|
| Dec 31, 2018 | $0.34 B |
15.26%
|
| Dec 29, 2017 | $0.30 B |
2,252.46%
|
| Dec 30, 2016 | $12.55 M |
-17.36%
|
| Dec 30, 2015 | $15.18 M |
-98.47%
|
| Dec 31, 2014 | $0.99 B |
709.56%
|
| Dec 31, 2013 | $0.12 B |
-39.80%
|
| Dec 28, 2012 | $0.20 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Sanofi
SNY
|
$124.64 B |
0.327 B
|
France
|
 Novo Nordisk
NVO
|
$285.37 B |
89.978 B
|
Denmark
|
 Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
USA
|
 AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
UK
|
 Pfizer
PFE
|
$125.57 B |
0.001 M
|
USA
|
 Merck
MRK
|
$196.28 B |
0.008 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
USA
|
 GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
UK
|
 Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
USA
|
 Novartis
NVS
|
$219.89 B |
0.932 B
|
Switzerland
|
 Amgen
AMGN
|
$149.09 B |
0.124 B
|
USA
|
 Biogen
BIIB
|
$17.36 B |
-0.001 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
USA
|
| Market Cap | = | ADOC.PA Stock Price | * | ADOC.PA Shares Outstanding |
| = | $4.39 | * | 18.05 M | |
| = | $79.21 M |